Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Spoor & FisherPaul Ramara from Spoor & Fisher explains the importance of relationship-building for brand owners dealing with enforcement authorities and customs officials -
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris looks at a recent judgment from the Athens Administrative Court of First Instance that favours the verbal elements of a trademark
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at how the Korean Intellectual Property Office (KIPO) and the Korean courts have judged the registrability and validity of pharmaceutical trademarks according to more specific criteria
-
Sponsored by Gün and PartnersUğur Aktekin and Zeynep Seda Alhas of Gün and Partners explore how the disruption caused by the coronavirus pandemic affected the enforcement of trademark rights in Turkey
-
Sponsored by AJ ParkAJ Park discusses the impact of the RCEP agreement on geographical indications and Māori traditional knowledge in New Zealand
-
Sponsored by GoldenGate LawyersBruce Fu of GoldenGate Lawyers explains the key changes that will streamline the registration procedure and better protect the interests of enterprises
